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Hippo signalingAutosomal Dominant Polycystic Kidney Disease (ADPKD) is an inherited systemic disease with intrarenal
cystogenesis as its primary characteristic. A variety of mouse models provided information on the
requirement of loss of balanced polycystin levels for initiation of cyst formation, the role of proliferation in
cystogenesis and the signaling pathways involved in cyst growth and expansion. Here we will review the
involvement of different signaling pathways during renal development, renal epithelial regeneration and cyst
formation in ADPKD, focusing on planar cell polarity (PCP) and oriented cell division (OCD). This will be
discussed in context of the hypothesis that aberrant PCP signaling causes cyst formation. In addition, the role
of the Hippo pathway, which was recently found to be involved in cyst growth and tissue regeneration, and
well-known for regulating organ size control, will be reviewed. The fact that Hippo signaling is linked to PCP
signaling makes the Hippo pathway a novel cascade in cystogenesis. The newly gained understanding of the
complex signaling network involved in cystogenesis and disease progression, not only necessitates reﬁning of
the current hypothesis regarding initiation of cystogenesis, but also has implications for therapeutic
intervention strategies. This article is part of a Special Issue entitled: Polycystic Kidney Disease.stic Kidney Disease.
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Polycystic kidney disease presents itself inmany different forms. In
this review we will focus on Autosomal Dominant Polycystic Kidney
Disease (ADPKD). ADPKD is a systemic disease with intrarenal
cystogenesis as its primary characteristic. Extra-renal manifestations
are hypertension, cardiac valvular abnormalities, cerebral aneurysms,
and cysts in liver and pancreas [1]. Usually, in young adults, only a
small number of cysts can be detected ultrasonographically, whereas
at middle age, thousands of cysts and ﬁbrotic tissue have replaced
almost all normal renal parenchyma and renal function declines.
In general, ADPKD patients carry one germ-line mutation and one
normal PKD1, or PKD2 allele. Renal cysts develop from somatic
inactivation of PKD1 or PKD2 by a 'two-hit' mechanism [2]. In addition,
haploinsufﬁciency, stochastic ﬂuctuations in PKD1or PKD2 gene
dosage below a tissue-speciﬁc threshold, may sufﬁce to cause cyst
formation [3]. Importantly, recent studies indicate that the picture can
bemore complex, since several families have been reportedwith non-
or incompletely penetrant alleles of PKD1 inherited at a homozygous
state, or in trans with another mutation [4,5].In kidneys the primary defect has been found to occur in the
epithelium. A balanced expression level of the PKD1 and 2 genes,
encoding polycystin 1 and 2 (PC1and PC2) is critical to maintain renal
epithelial architecture. Both PC1 and PC2 are expressed in several sub-
cellular compartments such as the primary cilium, cell–cell contacts
and cell-extracellular matrix contacts. They form different multimeric
protein complexes in the cell, modulating several signaling pathways,
which in concert control essential cellular functions such as prolifer-
ation, apoptosis, cell adhesion, and differentiation [6,7]. Disruption of
any of these processes can lead to cyst formation, as demonstrated by a
variety ofmousemodels [8–12]. In this review the role of proliferation,
injury and repair in ADPKD, as well as their different signaling path-
ways will be discussed, with the major focus on planar cell polarity
(PCP) and oriented cell division (OCD).2. Mechanism of disease
The renal pathogenesis of ADPKD recognizes several phases. In the
initiation phase, normal quiescent epithelial cells become hyper-
proliferative [13,14]. Subsequently, a phase characterized by cyst
growth and cyst expansion caused by proliferation of cystic epithelial
cells and increased ﬂuid secretion, as well as extracellular matrix
synthesis, can be recognized. During this phase also additional sig-
naling pathways become either activated, or dysfunctional, resulting
1250 H. Happé et al. / Biochimica et Biophysica Acta 1812 (2011) 1249–1255in more cyst growth [15]. These cysts detach from the original neph-
rons and continue to growth as isolated autonomous cysts.
Later on, cysts lining epithelial cells of large cysts stop dividing
and apoptotic nuclei can be found in these cysts [16]. In addition,
interstitial inﬂammatory inﬁltrates become apparent resulting in
tubulointerstitial ﬁbrosis and subsequent deterioration of kidney
function [17–19].
As the material obtained from kidneys of ADPKD patients mainly
allows investigation of the last phase of the disease,mousemodels had
to be developed in order to study the different stages of the disease.
3. Genetic mechanism in mice
Different Pkd1- or Pkd2-mutant mouse models have been created,
which are supporting the genetic mechanisms mentioned above. The
ﬁrst support for the second hit model was provided by the Pkd2ws25,−
model. In this model, with one null allele and one instable Pkd2 allele,
somatic rearrangements are accelerating renal cystic disease [20], while
mice that are heterozygous for an inactivating Pkd1 or Pkd2 mutation,
showonly a verymildphenotype. Homozygous Pkd1- and Pkd2-deﬁcient
mice, however, die at about embryonic stage 15.5 or directly after birth
because of severe cystic disease, vascular defects, and/or abnormalities of
the placental labyrinth [20–29]. On the other hand, mice carrying one
Pkd1 as well as one Pkd2 mutant allele are viable and show accelerated
renal cystic disease compared to the single gene phenotypes [29].
Also hypomorphic mouse models for polycystic kidney disease
that express Pkd1 or Pkd2 at a reduced level are viable, although they
develop severe PKD [30–32]. Extra-renal manifestations such as cysts
in liver and pancreas [21–23,28,33–35], and aortic dissecting
aneurysms have been reported as well [30,36]. However, the severity
of the phenotype and lifespan is dependent on the genetic background
of the mouse strain (unpublished results). The models with expanded
life span are especially useful for studying the later phases in PKD.
For proper renal development the levels of Pkd1 and Pkd2 gene
expression are critical, since over-expression leads to a renal cystic
phenotype [35,37–39], although in one model Pkd2-over-expression
did not cause cystic disease but renal tubulopathy [40]. In addition,
extra-renal manifestations similar to those observed in patients have
been described in a Pkd1 over-expression model [38], and over-
expression of a truncated Pkd2 gene caused polycystic kidney disease
and retinal degeneration in transgenic rats [41].
4. Inducible conditional deletion models
To overcome embryonic lethality and to study tissue-speciﬁc
effects of Pkd1-inactivation, inducible and conditional Pkd1 and Pkd2
deletion mice have been created, using the Cre-loxP system [42–48].
Thesemodels have provided valuable information on themechanisms
involved in the initiation phase of cyst formation. Inducible Pkd1-
deletion mice were used to analyze the kinetics of cyst formation
upon Pkd1-gene disruption at different time-points after birth. Inmice
the progressiveness of cystogenesis depends on the age of Pkd1-gene
disruption, e.g. in young mice the highest progression can be ob-
served, while adult mice show a very slow phenotype [43,45]. The
difference in progression of cystic renal disease correlates with the
developmental status of the renal tissue at the moment of gene
disruption as well as with its proliferative status [43,45]. Around
neonatal day 13, renal development enters its completion in mice and
a critical switch in gene expression was observed [45]. Also renal
epithelial cell proliferation is dramatically higher in neonatal
compared to adult mice [43]. Knocking-out Pkd1 at postnatal day 4
results in progressive cyst formation with the major involvement of
the distal nephron. At the moment of gene-inactivation, the distal
nephron is still elongating at that time, and shows many proliferating
cells [43]. Interestingly, Pkd1-gene disruption in young adult mice,
well beyond the above-mentioned developmental switch in genetranscription, leads to a disease progression rate intermediate to that
of neonatal and adult mice, while young adults also show levels of
renal epithelial cell proliferation between neonatal and adult mice,
[45,49]. Therefore, proliferation in the absence of functional poly-
cystins seems to be a trigger for cyst formation [49].
As proliferation seems to be an accelerating factor in cystogenesis
in young Pkd1-deletion mice, proliferation should also provide an
accelerating trigger for cyst formation in the kidneys from adult Pkd1-
deletion mice with low renal epithelial proliferation rates at the
moment of gene disruption. Indeed renal epithelial injury accelerates
the progression of cystogenesis in adult Pkd1-deletion mice [49,50].
However, it cannot be excluded that proliferation is not the only
accelerating factor, as epithelial regeneration probably shares (parts
of) the cellular programs involved in renal development.
Also in non-orthologous inducible, conditional knockout models for
renal cystic disease, in which kif3a or hnf1β is inactivated, injury ac-
celerates the cystic phenotype [51,52]. Although the mechanism
underlying cyst formation in the hnf1β conditional knock-outs probably
differs from themodel inwhich kif3awas deleted. In all of thesemodels
the nephron segment that is targeted by the injury, and in which
regeneration occurs, determines the origin of the majority of the cysts.
There are several possible answers to the question why prolifer-
ation accelerates cyst formation. One explanation may reside in the
fact that in quiescent cells epithelial junction complexes, where also
the polycystins can be found, are relatively stable but undergo ex-
tensive remodeling, when renal epithelial cells are forced to change
their quiescent state into either proliferation, or migration [53]. An-
other possibility is that the polycystins themselves are not stable, and
disappear from the junction complexes, but are crucial for proper
(re-) establishment of adhesion complexes [54,55].5. Altered ciliary signaling and planar cell polarity signaling
The primary cilium is a common denominator in renal cystic
diseases. This organelle harbors many of the proteins encoded by the
genesmutated in a variety of renal cystic diseases [56] i.e. genesmutated
in Bardet–Biedl syndrome [57], Meckel–Gruber syndrome [58–63],
nephronophthisis [64,65] or oral–facial–digital syndrome [66].
During development the primary cilia on renal epithelial cells
sense ﬂow upon the start of urine production. This is accompanied by
up-regulation and altered localization of the protein inversin. These
changes result in a switch from canonical to non-canonical Wnt sig-
naling, also known as the planar cell polarity (PCP) pathway [67].
PCP is polarity within the plane of an epithelial monolayer, parallel
to the basementmembrane and perpendicular to apical-basal polarity,
which represents as the (identical) spatial arrangement of cells or sub-
cellular structures of cells within an epithelial plane. The PCP pathway
is the signaling pathway that affects planar polarization of cells.
In PKD, however, defects in PCP signaling are found, as well as
increased canonical Wnt signaling [49,68,69]. A proper balance of these
pathways may be crucial for normal renal development and mainte-
nance of tissue homeostasis since persistent activation of theβ-catenin-
mediated Wnt signaling itself also causes renal cyst formation in trans-
genic mouse models [10,70].
Ciliary signaling and PCP signaling are closely linked; these two
pathways act bidirectional in regulating PCP and cilial/basal body
orientation. At least for motile cilia, PCP roughly provides cues for the
cilium since PCP dictates the orientation of the basal body, resulting in
synchronization of the beatingdirection ofmotile cilia in speciﬁc tissues.
On the other hand, orientation of cilia is optimized by hydrodynamic
forces, i.e. ﬂow [71–73], and PCP is required for positioning/proper
localization of cilia [74]. From these studiesMarshall concluded that the
cilia have a role in sensing the direction of ﬂuid ﬂow and by that can
provide cues for planar orientation of the cilium/basal body [75].
Correspondingly, proper orientation andpositioningof the basal bodyof
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hydrodynamic forces, although this remains to be conﬁrmed.
6. PCP and oriented cell division in development
It is proposed that PCP signaling is needed during renal develop-
ment in order to ensure the correct morphology and diameter of the
nephrons. Defects in PCP signaling may therefore cause an increase in
tubular diameter [76,77]. Fischer et al. concluded that renal epithelial
cells were planary polarized as cell division was oriented during renal
development. Orientation of cell division was indicated by the
orientation of the nuclear spindle along the longitudinal tubular
axis, depicted as the Y-direction in the tubule shown in Fig. 1A [77].
Therefore orientation of the nuclear spindle,measured by determining
mitotic angle of the nuclear spindle relative to the tubular longitudinal
axis, is now commonly used as a read-out for PCP signaling.
Using this method, misoriented cell division was observed in
developing kidneys and dilated tubules and in cysts in two murine
models for renal cystic disease [51,77]. These ﬁndings are consistent
with the concept that aberrant PCP signaling causes cyst formation.
This hypothesis was further supported by the development of renal
cysts in mice in which Fat4, a PCP component, was knocked-out [11].
In addition, in many mouse models presenting renal cysts, tubular
dilation and cyst formation are accompanied by aberrant oriented cell
division (OCD). However, these models are non-orthologous models
for PKD in which the targeted epithelial cells lack cilia [51,78], non-
canonical Wnt signaling is inﬂuenced by Wnt9b deﬁciency [79] or in
which cysts are formed upon unilateral ureteral obstruction [80].
Also for a Pkd1 conditional knockout model, misorientation of cell
division has been reported in pre-cystic epithelia [81]. This contrasts a
parallel publication, in which orientation of cell division was studied
in a Pkd1, Pkd2 and Pkhd1model. Aberrant OCD could not be observed
in pre-cystic tubules of Pkd1 and Pkd2-deletion mice. It was only
observed upon dilation of the tubules [82]. These different ﬁndings
between two independent studies on Pkd1 deletion mice may be
explained by the differences in analysis methods.Fig. 1. Oriented andmisoriented cell division in renal tubules. (A) Cell division within renal tu
the longitudinal axis of the tubule; in direction of the X-axis parallel to basal membrane
perpendicular to the basal membrane and the tubular longitudinal axis (B) Aberrant OCD wi
the plane of the epithelium). (C) Aberrant OCD with α2 describing the deviation from norm
both depict axis as represented in the vertical tubule shown in A. (D) Correct OCD in Y-direct
of the epithelial plane. OCD: oriented cell division.However, it is also possible that the accepted hypothesis, that
misoriented cell division is the cause of cyst formation, is incorrect or
incomplete, since a quite contrasting observation to the accepted
hypothesis wasmade in the latter study. In Pkhd1del4/del4mice, defective
OCD, including out of the epithelial plane cell division, into the lumen
was found. However, these mice failed to develop dilated tubules or
cystic kidneys.
Mitotic angles may deviate from the normal orientation in two
directions, described by two angles: the ﬁrst angle (α1) describes the
deviation from the longitudinal tubular axis which is represented by Y
in Fig. 1A, but parallel to the epithelial plane (XY-plane) as shown in
Fig. 1B. The second angle (α2) describes the angle between themitotic
spindle axis and the basal membrane, a cell division in the YZ-plane as
shown in Fig. 1C. Thus α2 deﬁnes how much the mitotic spindle axis
comes out of the epithelial plane. The paper of Nishio et al., studying
OCD in Pkhd1 mutant and Pkd1 and Pkd2-deletion mice, as discussed
above, is the ﬁrst that (clearly) discriminated between these two
angles. They showed thatmisorientation of cell division occurs in both
directions, at least clearly shown formildly dilated tubules in Pkd1 and
Pkd2-deletion mice [82]. In addition, they suggested that cell division
out of the plane of the epithelium in Pkhd1del4,del4, was probably
corrected by a convergent extension-likemovement into the epithelial
plane of cells, resulting in an increased number of tubular circumfer-
ential cells but not in cystic kidneys [82]. It cannot be excluded how-
ever, that other factors may explain the lack of cyst formation in
Pkhd1del4/del4, e.g. the complex processing of the Pkhd1 transcript.
Thus, misorientation of cell division includes cell divisions out of the
planeof the epithelium.Not in everymodelmisoriented cell division can
be designated as the cause of cyst formation, since cytogenesis can
develop without loss of OCD. In addition, aberrant orientation of cell
division alone seems not to be sufﬁcient for cyst formation and rather
seems to be a permissive condition or an accelerating factor for tubular
dilatation.
It cannot be excluded, however, that cyst formation and renal cystic
disease in the commonest and more adult-onset form of polycystic
disease, ADPKD, are mechanistically different from the processesbular epithelium is possible in three directions: in the direction of the Y-axis; parallel to
and perpendicular to the tubular longitudinal axis or in the direction of the Z-axis;
th α1 describing the deviation from normal OCD in X-direction within the XY-plane (in
al OCD in Z-direction within the YZ-plane (out of the plane of the epithelium). B and C
ion (left) and aberrant OCD with a deviation into Z-direction (right) i.e. cell division out
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ticularly the ciliopathies.
7. PCP and oriented cell division in renal epithelial regeneration
It is likely that the complex interplay of processes involved during
renal development; e.g. PCP signaling, OCD, convergent extension and
ciliary signaling are also involved during regeneration of tubular
epithelia. PCP signaling has already proven to be important for proper
tubular epithelial repair [80]. To ensure correct tubular morphology
during repair, the majority of the mitotic angles have to be parallel to
the tubular longitudinal axis.
Reports in which OCD was examined after injury in two different
models for PKD, a Pkd1 and an Hnf1β deletion model, showed that the
orientation of mitotic spindles during repair in controls is preferen-
tially directed along the tubular (longitudinal) axis [52,81]. This
suggests that, like in developing nephrons, there is planar polarization
of the epithelial cells.
As in renal development, the Pkd1 and an Hnf1β deletion model
showmisoriented cell division during regeneration [52,81]. However,
measurement of the mitotic angle can only be done in dividing cells.
As the centrosomes form the spindle poles during cell division, OCD
and centrosome position are linked [78], the position of centrosomes
may be used as a read-out for PCP in non-dividing cells. This is
supported by the observation that disrupting PCP components, lead to
aberrant positioning of the basal body/centrosome and cilium
[73,74,83,84]. Also in adult Pkd1-deletion mice mispositioning of the
centrosome was observed during the pre-cystic phase after comple-
tion of repair [49]. These data indicate that aberrant PCP precedes cyst
formation, although mispositioning of the centrosome was also found
in tubules of adult Pkd1-deletion mice that were not subjected to
epithelial injury, and develop cysts rather late [49].
8. Planar cell polarity and apical-basal polarity
OCD is accepted as a read-out for PCP as PCP signaling regulates
OCD. However, OCD is not regulated by the PCP pathway alone. PCP
signaling provides spatial information within the epithelial sheet.
Other signaling pathways provide information concerning apical-
basal polarity and regulate the direction of cell division perpendicular
to the epithelial sheet, depicted as the Z-direction shown in Figs. 1A
and D (resembling asymmetric cell division known from stem-cell
biology and neuronal development [85,86]). Fig. 1D shows a cell
division in Y-direction, parallel with the plane of the epithelium, and
one in the Z-direction, parallel to apical–basal polarity.
The Par3/Par6 complex, including Cdc42 and aPKC, is required for
establishing and maintaining polarized cortical domains in a wide
variety of epithelia [87–90]. Thus this complex is implicated in apical–
basal polarity and also regulates OCD [91]. Additionally, signaling
complexes connected to adherens junctions, and cell-extracellular
matrix contacts also provide input for the orientation of cell division
[92–95]. At these locations, polycystin-1 and 2 modulate signaling of
multi-protein complexes [6].
9. Signaling pathways involved in cyst expansion
A large variety of cellular changes in cyst-lining cells has been
observed, and in the last decade it became clear that the polycystins
transmit extracellular signals to the nucleus via multiple signaling
pathways. A prominent role in cyst growth has been proposed for
reduced Ca2+ inﬂux, cAMP accumulation and aberrant Ras/Raf/ERK
activation [96,97]. Other proposed mechanisms involve activation of
G-proteins, mTOR, PI3-kinase, Jak2-STAT1/3, NFAT (nuclear factor of
activated T cells), and NF-kB (nuclear factor kappa B) signaling [98–
100]. It cannot be excluded that some of these pathways or second
messengers, e.g. Ca2+, are involved in the early initiation steps of cystformation. However, these pathways are to a large extend involved in
proliferation, and thereby in cyst expansion.
Tubulointerstitial ﬁbrosis is a major process contributing to the
pathology towards end-stage renal disease and is a feature of later
stages in ADPKD disease progression. A key regulator of ﬁbrosis is the
TGFβ-signaling cascade. Indeed, in human tissues and inmouse models
phosphorylation and nuclear translocation of the TGFβ cascade actor,
SMAD2 has been detected inmore progressive but not in early stages of
the disease [101].
Recent data also indicated the involvement of the Hippo pathway
in renal cystic disease. This pathway was ﬁrst known to be important
in organ and tissue size control in Drosophila. The core components of
the DrosophilaHippo pathway are well conserved and also function as
tumor suppressors in mammals in addition to regulating growth in
terms of organ size control [102]. The Hippo signaling pathway exerts
its actions in mammals by controlling the transcription of genes
involved in proliferation and apoptosis through the transcriptional co-
activator and ﬁnal effector molecule, YAP and its ortholog TAZ.
In PKD, Hippo signaling showed altered activity [103]. YAP, a
transcriptional co-activator and ﬁnal effector molecule of the Hippo
pathway, was observed in nuclei of dilated tubules and cyst in injury-
induced Pkd1-deletion mice. Even more, disturbed Hippo signaling
causedby, e.g. deregulation of YAP [104,105] or TAZ (Wwtr1) deﬁciency
[105–107], resulted in cyst formation. The observed altered activity of
the Hippo pathway can provide a proliferative driving force for cyst
expansion.
Fascinatingly, YAP/TAZ are transcriptional co-activators for a
variety of transcription factors, e.g. TEAD, Glis3, SMAD, ErbB4-CTF,
p73, Runx2, many of them implicated in polycystic kidney disease
[69,102,108–110]. Also it has been reported that the canonical Wnt
signaling, one of the signaling cascades altered in cystic epithelia, is
modulated by Hippo signaling [49,68,69,111].
As PCP signaling provides directional information, Hippo signaling
is known to control organ size, and possibly provides information
about the number of tubular circumferential cells. In other words, PCP
signaling tells which direction, Hippo signaling dictates how many
cells in each direction. In order to coordinate these processes there
must be crosstalk between the Hippo pathway and the PCP pathway.
In fact, crosstalk between these pathways is possible since the up-
stream regulators of the Hippo pathway are shared with the PCP
pathway; i.e. Fat, Four-jointed and Dachsous [112].
Although, nuclear YAP was not observed in tubular epithelial cells
prior to tubular dilation and cyst formation [103,113], it cannot be
excluded that reduced activity of the Hippo pathway is already
involved in the initiation of cyst formation. Asmentioned above, Fat4 is
in addition to a PCP component, also a regulator of the Hippo pathway.
Therefore, it is possible that cyst formation in fat4−/−micemay in fact
be attributed to a disbalance of Hippo and PCP signaling [11].
Also in tissue regeneration the Hippo pathway is involved. Nuclear
and strong cytoplasmic accumulation of YAP is observed during
epithelial regeneration in the gut [114] and a similar phenomenon
was observed for the kidneys [103]. Overall these data imply that the
delicate interplay between PCP and Hippo signaling may also be
important for tissue regeneration after injury.
10. Future prospects in ADPKD research
The animal models showed us the vastness and complexity of
signaling pathways involved in cyst formation and disease progression.
These pathways act in a concerted fashion as components of an
interconnected signaling network. Experimental data also provided us,
sometimes, with apparently conﬂicting results, which can mostly be
explained by differences in experimental conditions and data interpre-
tation. The conﬂicting results concerning PCP signaling demand us to
systematically (re-)analyze our data concerning the orientation of
mitotic spindle axis. This will enable us to reﬁne our hypothesis further
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help us dissect the role of the pathways implicated.
The complexity of the involved signaling networks suggest that it
may be too ambitious and probably naive to think that prevention
of cyst formation and delay of renal failure can be accomplished by
targeting a single pathway. In patients cyst formation is not synchro-
nized and areas with different phases of the disease can be found in the
kidneys of an individual patient. Probably, therapy with drugs that
targetmore than one signaling pathwaywill be necessary and probably
more successful than treatment with single-target medication.References
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